{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T19:29:08Z","timestamp":1784662148055,"version":"3.55.0"},"reference-count":22,"publisher":"The Endocrine Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,9,1]]},"abstract":"<jats:sec>\n                  <jats:title>Context:<\/jats:title>\n                  <jats:p>Autosomal dominant hypophosphatemic rickets (ADHR) is the only hereditary disorder of renal phosphate wasting in which patients may regain the ability to conserve phosphate. Low iron status plays a role in the pathophysiology of ADHR.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective:<\/jats:title>\n                  <jats:p>This study reports of a girl with ADHR, iron deficiency, and a paternal history of hypophosphatemic rickets that resolved without treatment. The girl's biochemical phenotype resolved with iron supplementation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Subjects:<\/jats:title>\n                  <jats:p>A 26-month-old girl presented with typical features of hypophosphatemic rickets, short stature (79 cm; \u22122.82 SDS), and iron deficiency. Treatment with elemental phosphorus and calcitriol improved her biochemical profile and resolved the rickets. The girl's father had presented with rickets at age 11 months but never received medication. His final height was reduced (154.3 cm; \u22123.51 SDS), he had undergone corrective leg surgery and had an adult normal phosphate, fibroblast growth factor 23, and iron status. Father and daughter were found to have a heterozygous mutation in exon 3 of the FGF23 gene (c.536G&amp;gt;A, p.Arg179Gln), confirming ADHR.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Intervention:<\/jats:title>\n                  <jats:p>Withdrawal of rickets medication was attempted off and on iron supplementation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results:<\/jats:title>\n                  <jats:p>Withdrawal of rickets medication in the girl was unsuccessful in the presence of low-normal serum iron levels at age 5.6 years but was later successful in the presence of high-normal serum iron levels following high-dose iron supplementation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions:<\/jats:title>\n                  <jats:p>We report an association between iron supplementation and a complete loss of biochemical ADHR phenotype, allowing withdrawal of rickets medication. Experience from this case suggests that reduction and withdrawal of rickets medication should be attempted only after iron status has been optimized.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/jc.2015-2391","type":"journal-article","created":{"date-parts":[[2015,7,17]],"date-time":"2015-07-17T17:00:50Z","timestamp":1437152450000},"page":"3388-3392","source":"Crossref","is-referenced-by-count":46,"title":["Iron Supplementation Associated With Loss of Phenotype in Autosomal Dominant Hypophosphatemic Rickets"],"prefix":"10.1210","volume":"100","author":[{"given":"Klaus","family":"Kapelari","sequence":"first","affiliation":[{"name":"Department of Pediatrics (K.K., J.K.), Medical University of Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"K\u00f6hle","sequence":"additional","affiliation":[{"name":"Department of Pediatrics (K.K., J.K.), Medical University of Innsbruck, 6020 Innsbruck, Austria"},{"name":"Department of Pediatrics (J.K.), Technische Universit\u00e4t M\u00fcnchen, 80333 M\u00fcnchen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Kotzot","sequence":"additional","affiliation":[{"name":"Division of Human Genetics, Department for Medical Genetics, Molecular and Clinical Pharmacology (D.K.), Medical University of Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"H\u00f6gler","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes (W.H.), Birmingham Children's Hospital, Birmingham B4 6NH, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"issue":"2","key":"2020071619145392500_B1","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1210\/jcem.82.2.3765","article-title":"Autosomal dominant hypophosphatemic rickets\/osteomalacia: Clinical characterization of a novel renal phosphate-wasting disorder","volume":"82","author":"Econs","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2020071619145392500_B2","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1046\/j.1523-1755.2001.00064.x","article-title":"Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23","volume":"60","author":"White","year":"2001","journal-title":"Kidney Int"},{"issue":"3","key":"2020071619145392500_B3","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/81664","article-title":"Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23","volume":"26","author":"ADHR Consortium","year":"2000","journal-title":"Nat Genet"},{"issue":"5","key":"2020071619145392500_B4","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1365-2443.2005.00853.x","article-title":"Fibroblast growth factor 23 reduces expression of type IIa Na+\/Pi co-transporter by signaling through a receptor functionally distinct from the known FGFRs in opossum kidney cells","volume":"10","author":"Yan","year":"2005","journal-title":"Genes Cells"},{"issue":"3","key":"2020071619145392500_B5","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J Bone Miner Res"},{"issue":"5","key":"2020071619145392500_B6","doi-asserted-by":"crossref","first-page":"F1577","DOI":"10.1152\/ajprenal.00463.2006","article-title":"Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1alpha-hydroxylase expression in vitro","volume":"293","author":"Perwad","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"issue":"11","key":"2020071619145392500_B7","doi-asserted-by":"crossref","first-page":"9843","DOI":"10.1074\/jbc.M210490200","article-title":"The autosomal dominant hypophosphatemic rickets R176Q mutation in fibroblast growth factor 23 resists proteolytic cleavage and enhances in vivo biological potency","volume":"278","author":"Bai","year":"2003","journal-title":"J Biol Chem"},{"issue":"6","key":"2020071619145392500_B8","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1046\/j.1523-1755.2003.00328.x","article-title":"Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers","volume":"64","author":"Larsson","year":"2003","journal-title":"Kidney Int"},{"issue":"7","key":"2020071619145392500_B9","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1359\/jbmr.2003.18.7.1227","article-title":"Serum FGF23 levels in normal and disordered phosphorus homeostasis","volume":"18","author":"Weber","year":"2003","journal-title":"J Bone Miner Res"},{"issue":"11","key":"2020071619145392500_B10","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1210\/jc.2011-1239","article-title":"Iron modifies plasma FGF23 differently in autosomal dominant hypophosphatemic rickets and healthy humans","volume":"96","author":"Imel","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2020071619145392500_B11","first-page":"305","article-title":"Loss of renal phosphate wasting in a child with autosomal dominant hypophosphatemic rickets caused by a FGF23 mutation","volume":"55","author":"Kruse","year":"2001","journal-title":"Horm Res"},{"issue":"2","key":"2020071619145392500_B12","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.bone.2012.11.012","article-title":"Autosomal dominant hypophosphatemic rickets in an 85 year old woman: characterization of her disease from infancy through adulthood","volume":"52","author":"Seton","year":"2013","journal-title":"Bone"},{"issue":"Pt 5","key":"2020071619145392500_B13","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1258\/000456307781646102","article-title":"The association of circulating ferritin with serum concentrations of fibroblast growth factor-23 measured by three commercial assays","volume":"44","author":"Durham","year":"2007","journal-title":"Ann Clin Biochem"},{"issue":"46","key":"2020071619145392500_B14","doi-asserted-by":"crossref","first-page":"E1146","DOI":"10.1073\/pnas.1110905108","article-title":"Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice","volume":"108","author":"Farrow","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2020071619145392500_B15","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.clinbiochem.2014.12.027","article-title":"Plasma fibroblast growth factor 23 concentration and iron status. Does the relationship exist in the elderly population?","volume":"48","author":"Bozentowicz-Wikarek","year":"2015","journal-title":"Clin Biochem"},{"issue":"8","key":"2020071619145392500_B16","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1002\/jbmr.1923","article-title":"Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women","volume":"28","author":"Wolf","year":"2013","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2020071619145392500_B17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EC-13-0070","article-title":"Predictors of intact and C-terminal fibroblast growth factor 23 in Gambian children","volume":"3","author":"Braithwaite","year":"2014","journal-title":"Endocr Connect"},{"key":"2020071619145392500_B18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bone.2013.12.001","article-title":"Iron and fibroblast growth factor 23 in X-linked hypophosphatemia","volume":"60","author":"Imel","year":"2014","journal-title":"Bone"},{"issue":"1","key":"2020071619145392500_B19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1687-9856-2012-27","article-title":"FGF23 is correlated with iron status but not with inflammation and decreases after iron supplementation: a supplementation study","volume":"2012","author":"Braithwaite","year":"2012","journal-title":"Int J Pediatr Endocrinol"},{"issue":"4","key":"2020071619145392500_B20","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.bone.2009.06.017","article-title":"Hypophosphatemia induced by intravenous administration of saccharated ferric oxide: another form of FGF23-related hypophosphatemia","volume":"45","author":"Shimizu","year":"2009","journal-title":"Bone"},{"issue":"2","key":"2020071619145392500_B21","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/jbmr.2049","article-title":"Neonatal iron deficiency causes abnormal phosphate metabolism by elevating FGF23 in normal and ADHR mice","volume":"29","author":"Clinkenbeard","year":"2014","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2020071619145392500_B22","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1359\/jbmr.070107","article-title":"FGF23 concentrations vary with disease status in autosomal dominant hypophosphatemic rickets","volume":"22","author":"Imel","year":"2007","journal-title":"J Bone Miner Res"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/100\/9\/3388\/10435576\/jcem3388.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/100\/9\/3388\/10435576\/jcem3388.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T04:21:17Z","timestamp":1594959677000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/100\/9\/3388\/2836068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,1]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2015-2391","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,1]]}}}